The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.
Citing people familiar with the matter, The Journal reported that Starboard approached former Pfizer CEO Ian Read and CFO ...
AbbVie’s immunology duo Skyrizi and Rinvoq is, in a rare blip this year, not leading the pharma DTC monthly rankings as ...
Pfizer's stock has struggled due to declining demand for COVID-19 treatments, but activist investor Starboard's $1 billion ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
No large pharma company has traversed this decade's ups and downs quite like Pfizer. | No large pharma company has traversed ...
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country ...